These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 19002212)

  • 1. When linkage signal for autism MET candidate gene.
    Campbell DB
    Eur J Hum Genet; 2009 Jun; 17(6):699-700. PubMed ID: 19002212
    [No Abstract]   [Full Text] [Related]  

  • 2. A surprising METamorphosis: autism genetics finds a common functional variant.
    State MW
    Proc Natl Acad Sci U S A; 2006 Nov; 103(45):16621-2. PubMed ID: 17075042
    [No Abstract]   [Full Text] [Related]  

  • 3. Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions.
    Campbell DB; Buie TM; Winter H; Bauman M; Sutcliffe JS; Perrin JM; Levitt P
    Pediatrics; 2009 Mar; 123(3):1018-24. PubMed ID: 19255034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genetic variant that disrupts MET transcription is associated with autism.
    Campbell DB; Sutcliffe JS; Ebert PJ; Militerni R; Bravaccio C; Trillo S; Elia M; Schneider C; Melmed R; Sacco R; Persico AM; Levitt P
    Proc Natl Acad Sci U S A; 2006 Nov; 103(45):16834-9. PubMed ID: 17053076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MET and autism susceptibility: family and case-control studies.
    Sousa I; Clark TG; Toma C; Kobayashi K; Choma M; Holt R; Sykes NH; Lamb JA; Bailey AJ; Battaglia A; Maestrini E; Monaco AP;
    Eur J Hum Genet; 2009 Jun; 17(6):749-58. PubMed ID: 19002214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder.
    Campbell DB; Li C; Sutcliffe JS; Persico AM; Levitt P
    Autism Res; 2008 Jun; 1(3):159-68. PubMed ID: 19360663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further evidence that the rs1858830 C variant in the promoter region of the MET gene is associated with autistic disorder.
    Jackson PB; Boccuto L; Skinner C; Collins JS; Neri G; Gurrieri F; Schwartz CE
    Autism Res; 2009 Aug; 2(4):232-6. PubMed ID: 19681062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunogenetic aspects of autism. Review].
    Pardo-Govea T; Solís-Añez E
    Invest Clin; 2009 Sep; 50(3):393-406. PubMed ID: 19961061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of cerebral cortex MET signaling in autism spectrum disorder.
    Campbell DB; D'Oronzio R; Garbett K; Ebert PJ; Mirnics K; Levitt P; Persico AM
    Ann Neurol; 2007 Sep; 62(3):243-50. PubMed ID: 17696172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders.
    Levitt P; Campbell DB
    J Clin Invest; 2009 Apr; 119(4):747-54. PubMed ID: 19339766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Met proto-oncogene juxtamembrane rare variations in mouse and humans: differential effects of Arg and Cys alleles on mouse lung tumorigenesis.
    Zaffaroni D; Spinola M; Galvan A; Falvella FS; Pazzaglia S; Saran A; Mancuso MT; Galbiati F; Pignatiello C; Cabrera W; Ibanez O; Manenti G; Dragani TA
    Oncogene; 2005 Feb; 24(6):1084-90. PubMed ID: 15592501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linkage and association of the mitochondrial aspartate/glutamate carrier SLC25A12 gene with autism.
    Ramoz N; Reichert JG; Smith CJ; Silverman JM; Bespalova IN; Davis KL; Buxbaum JD
    Am J Psychiatry; 2004 Apr; 161(4):662-9. PubMed ID: 15056512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The function, proteolytic processing, and histopathology of Met in cancer.
    Hanna JA; Bordeaux J; Rimm DL; Agarwal S
    Adv Cancer Res; 2009; 103():1-23. PubMed ID: 19854350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notch4 gene polymorphisms are not associated with autism in Japanese population.
    Koishi S; Yamazaki K; Yamamoto K; Koishi S; Enseki Y; Nakamura Y; Oya A; Yasueda M; Asakura A; Aoki Y; Atsumi M; Inomata J; Inoko H; Matsumoto H
    Am J Med Genet B Neuropsychiatr Genet; 2004 Feb; 125B(1):61-2. PubMed ID: 14755446
    [No Abstract]   [Full Text] [Related]  

  • 15. Activation of MET by gene amplification or by splice mutations deleting the juxtamembrane domain in primary resected lung cancers.
    Onozato R; Kosaka T; Kuwano H; Sekido Y; Yatabe Y; Mitsudomi T
    J Thorac Oncol; 2009 Jan; 4(1):5-11. PubMed ID: 19096300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 7q: where autism meets language disorder?
    Folstein SE; Mankoski RE
    Am J Hum Genet; 2000 Aug; 67(2):278-81. PubMed ID: 10889044
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence of linkage between the serotonin transporter and autistic disorder.
    Cook EH; Courchesne R; Lord C; Cox NJ; Yan S; Lincoln A; Haas R; Courchesne E; Leventhal BL
    Mol Psychiatry; 1997 May; 2(3):247-50. PubMed ID: 9152989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MET receptor tyrosine kinase as an autism genetic risk factor.
    Peng Y; Huentelman M; Smith C; Qiu S
    Int Rev Neurobiol; 2013; 113():135-65. PubMed ID: 24290385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No evidence of ARAF, CRAF and MET mutations in BRAFT1799A negative human papillary thyroid carcinoma.
    Kumagai A; Namba H; Takakura S; Inamasu E; Saenko VA; Ohtsuru A; Yamashita S
    Endocr J; 2006 Oct; 53(5):615-20. PubMed ID: 16896265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer: mixing cocktails.
    Sawyers CL
    Nature; 2007 Oct; 449(7165):993-6. PubMed ID: 17960228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.